BIOSYNTHESIS OF HUMAN ACUTE-PHASE SERUM AMYLOID A-PROTEIN (A-SAA) INVITRO - THE ROLES OF MESSENGER-RNA ACCUMULATION, POLY(A) TAIL SHORTENING AND TRANSLATIONAL EFFICIENCY

Citation
Dm. Steel et al., BIOSYNTHESIS OF HUMAN ACUTE-PHASE SERUM AMYLOID A-PROTEIN (A-SAA) INVITRO - THE ROLES OF MESSENGER-RNA ACCUMULATION, POLY(A) TAIL SHORTENING AND TRANSLATIONAL EFFICIENCY, Biochemical journal, 291, 1993, pp. 701-707
Citations number
40
Categorie Soggetti
Biology
Journal title
ISSN journal
02646021
Volume
291
Year of publication
1993
Part
3
Pages
701 - 707
Database
ISI
SICI code
0264-6021(1993)291:<701:BOHASA>2.0.ZU;2-D
Abstract
Human 'acute-phase' serum amyloid A protein (A-SAA) is a major acute-p hase reactant (APR) and an apolipoprotein of high density lipoprotein 3 (HDL3). We have examined several parameters of A-SAA biosynthesis in PLC/PRF/5 hepatoma cells in response to monocyte conditioned medium ( MoCM) and dual treatment with interleukin-1beta and interleukin-6 (IL- 1beta+IL-6). Treatment of PLC/PRF/5 cells with MoCM or IL-1beta+IL-6 c aused a dramatic and rapid increase in A-SAA mRNA and protein synthesi s; A-SAA mRNA was first detectable at 3 h, with peak levels reached by 24 h. A-SAA mRNA accumulation is accompanied by a gradual and homogen eous decrease in the length of the A-SAA poly(A) tail; the poly(A) tai l shortening does not apparently affect the intrinsic stability of A-S AA mRNA. Analysis of RNA isolated from the ribonucleoprotein, monosome and polysome fractions of cytokine-treated PLC/PRF/5 cells showed tha t most A-SAA mRNA was associated with small polyribosomes, regardless of time post-stimulus, suggesting that the translational efficiency of A-SAA mRNA is constant throughout cytokine-driven induction. Moreover , the transit time of A-SAA protein out of the cell is also constant t hroughout the time course of induction. These data provide evidence of a paradox with regard to the transcriptional up-regulation of A-SAA b y IL-1beta+IL-6 and the relative synthesis of A-SAA protein and sugges t a role for post-transcriptional control of A-SAA biosynthesis during the acute phase.